Details for New Drug Application (NDA): 088873
✉ Email this page to a colleague
NDA 088873 describes ENLON, which is a drug marketed by Norvium Bioscience and is included in three NDAs. Additional details are available on the ENLON profile page.
The generic ingredient in ENLON is atropine sulfate; edrophonium chloride. There are twenty-three drug master file entries for this compound. Additional details are available on the atropine sulfate; edrophonium chloride profile page.
The generic ingredient in ENLON is atropine sulfate; edrophonium chloride. There are twenty-three drug master file entries for this compound. Additional details are available on the atropine sulfate; edrophonium chloride profile page.
Summary for 088873
| Tradename: | ENLON |
| Applicant: | Norvium Bioscience |
| Ingredient: | edrophonium chloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 088873
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/ML | ||||
| Approval Date: | Aug 6, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
